Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1628-1632
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ai, M.
Right arrow Articles by Reaven, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ai, M.
Right arrow Articles by Reaven, G. M.

CLINICAL STUDY

Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes

Masumi Ai, MD*, Akira Tanaka, MD*,*, Keiko Ogita, MD{dagger}, Masaaki Sekinc, MD{dagger}, Fujie Numano, MD{dagger}, Fujio Numano, MD* and Gerald M. Reaven, MD{ddagger}

* Third Department of Internal Medicine, Tokyo Medical and Dental University, Tokyo, Japan
{dagger} Department of Internal Medicine, Tokyo Metropolitan Kiyose Hospital, Tokyo, Japan
{ddagger} Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

Manuscript received January 17, 2001; revised manuscript received July 18, 2001, accepted August 15, 2001.

* Reprint requests and correspondence: Dr. Akira Tanaka, Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan 113-8519
tanaka.med3{at}med.tmd.ac.jp

OBJECTIVES

The goal of this study was to evaluate the relative effects of hyperglycemia and hyperinsulinemia on postprandial remnant lipoprotein (RLP) concentrations in newly diagnosed type 2 diabetics.

BACKGROUND

Increases in fasting RLP concentration have been described in type 2 diabetics, as well as in insulin-resistant nondiabetics. Given the atherogenicity of RLPs, we have extended these observations by assessing postprandial RLP concentrations and observing that hyperglycemia was necessary for the increase in RLP concentrations.

METHODS

Patients with type 2 diabetes were subdivided on the basis of their plasma insulin response to oral glucose into hyperinsulinemic (H-DM) and normoinsulinemic (N-DM) groups of 15 patients each. Plasma triglyceride (TG), RLP-TG and RLP cholesterol (RLP-C) concentrations were determined before and 2 and 4 h after an oral fat load in these patients and 10 control (CTL) subjects.

RESULTS

Plasma TG, RLP-TG and RLP-C concentrations peaked 2 h after the fat load in the CTL group, returning to baseline within 4 h. In contrast, concentrations of these variables increased throughout the 4-h study in both groups of patients with type 2 diabetes. Total integrated plasma RLP-TG and RLP-C responses above baseline after the oral fat load were significantly higher in the H-DM group compared with the CTL (p = 0.019 and 0.009, respectively) or N-DM (p = 0.026 and 0.029, respectively) groups. Post-heparin lipoprotein lipase activities and apo E phenotypes were similar in the H-DM and N-DM groups.

CONCLUSIONS

Remnant lipoprotein response to an oral fat load is significantly increased in hyperinsulinemic patients with type 2 diabetes. These changes may increase the risk of coronary heart disease in these individuals.

Abbreviations and Acronyms
  apo = apolipoprotein
  BMI = body mass index
  C = cholesterol
  CHD = coronary heart disease
  CTL = healthy volunteers
  HDL = high-density lipoprotein
  H-DM = hyperinsulinemic patient with type 2 diabetes
  LPL = lipoprotein lipase
  N-DM = normoinsulinemic patient with type 2 diabetes
  OPTT = oral fat tolerance test
  RLP = remnant lipoprotein
  RLP-C = remnant lipoprotein cholesterol
  RLP-TG = remnant lipoprotein triglyceride
  TG = triglyceride




This article has been cited by other articles:


Home page
J. Nutr.Home page
A. M. J. van Hees, W. H. M. Saris, G. M. Dallinga-Thie, G. B. Hul, J. A. Martinez, J.-M. Oppert, V. Stich, A. Astrup, P. Arner, T. I. A. Sorensen, et al.
Fasting and Postprandial Remnant-Like Particle Cholesterol Concentrations in Obese Participants Are Associated with Plasma Triglycerides, Insulin Resistance, and Body Fat Distribution
J. Nutr., December 1, 2008; 138(12): 2399 - 2405.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Ai, A. Tanaka, K. Ogita, and K. Shimokado
Favorable Effects of Early Insulin Secretion by Nateglinide on Postprandial Hyperlipidemia in Patients With Type 2 Diabetes
Diabetes Care, May 1, 2006; 29(5): 1180 - 1180.
[Full Text] [PDF]


Home page
CirculationHome page
T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman
Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
Circulation, April 27, 2004; 109(16): 1918 - 1925.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement